Bank of New York Mellon’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-27,317
| Closed | -$5K | – | 4319 |
|
|
2019
Q1 | $5K | Sell |
27,317
-798
| -3% | -$146 | ﹤0.01% | 4194 |
|
|
2018
Q4 | $20K | Hold |
28,115
| – | – | ﹤0.01% | 4153 |
|
|
2018
Q3 | $35K | Hold |
28,115
| – | – | ﹤0.01% | 4154 |
|
|
2018
Q2 | $31K | Sell |
28,115
-7,907
| -22% | -$8.72K | ﹤0.01% | 4133 |
|
|
2018
Q1 | $73K | Buy |
36,022
+7,907
| +28% | +$16K | ﹤0.01% | 4096 |
|
|
2017
Q4 | $34K | Hold |
28,115
| – | – | ﹤0.01% | 4235 |
|
|
2017
Q3 | $35K | Hold |
28,115
| – | – | ﹤0.01% | 4165 |
|
|
2017
Q2 | $37K | Sell |
28,115
-84,671
| -75% | -$111K | ﹤0.01% | 4173 |
|
|
2017
Q1 | $210K | Buy |
112,786
+149
| +0.1% | +$277 | ﹤0.01% | 3865 |
|
|
2016
Q4 | $583K | Buy |
112,637
+3,589
| +3% | +$18.6K | ﹤0.01% | 3519 |
|
|
2016
Q3 | $608K | Buy |
109,048
+5,891
| +6% | +$32.8K | ﹤0.01% | 3441 |
|
|
2016
Q2 | $572K | Buy |
103,157
+7,931
| +8% | +$44K | ﹤0.01% | 3454 |
|
|
2016
Q1 | $419K | Buy |
95,226
+18,138
| +24% | +$79.8K | ﹤0.01% | 3514 |
|
|
2015
Q4 | $464K | Buy |
77,088
+9,700
| +14% | +$58.4K | ﹤0.01% | 3544 |
|
|
2015
Q3 | $527K | Buy |
67,388
+8,391
| +14% | +$65.6K | ﹤0.01% | 3533 |
|
|
2015
Q2 | $361K | Buy |
58,997
+45,982
| +353% | +$281K | ﹤0.01% | 3730 |
|
|
2015
Q1 | $105K | Buy |
+13,015
| New | +$105K | ﹤0.01% | 4026 |
|